DISCOVERY: A Study Examining the Prevalence of TTR Mutations in Subjects Suspected of Having Cardiac Amyloidosis
Completed
Conditions studied: Familial Amyloidotic Cardiomyopathy (FAC)
In brief
The purpose of this study is to characterize the frequency of TTR mutations in subjects suspected of having cardiac amyloidosis
Key facts
- Study ID
- NCT02252653
- Run by
- Alnylam Pharmaceuticals
- People needed
- 1010
- Starts
- 2014-06-01
- Expected to finish
- 2016-03-01
- Last updated by the study team
- 2016-07-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males or females >18 years old
- History of evidence suggestive of cardiac amyloidosis
- Subject is willing and able to comply with protocol required assessments and provide written informed consent
You may not qualify if…
- Known diagnosis of primary (AL) amyloidosis
- Known diagnosis of hereditary cardiomyopathy or cardiomyopathy due to aortic stenosis
- Patient is currently pregnant
Where it is running
- Clinical Trial Site — Bakersfield, California, United States
- Clinical Trial Site — La Mesa, California, United States
- Clinical Trial Site — Los Angeles, California, United States
- Clinical Trial Site — Los Angeles, California, United States
- Clinical Trial Site — San Francisco, California, United States
- Clinical Trial Site — Torrance, California, United States
- Clinical Trial Site — Aurora, Colorado, United States
- Clinical Trial Site — Washington D.C., District of Columbia, United States
- Clinical Trial Site — Washington D.C., District of Columbia, United States
- Clinical Trial Site — Washington D.C., District of Columbia, United States
- Clinical Trial Site — Tampa, Florida, United States
- Clinical Trial Site — Athens, Georgia, United States
- Clinical Trial Site — Atlanta, Georgia, United States
- Clinical Trial Site — Atlanta, Georgia, United States
- Clinical Trial Site — Macon, Georgia, United States
- Clinical Trial Site — Chicago, Illinois, United States
- Clinical Trial Site — Chicago, Illinois, United States
- Clinical Trial Site — Chicago, Illinois, United States
- Clinical Trial Site — Merrillville, Indiana, United States
- Clinical Trial Site — Baltimore, Maryland, United States
- Clinical Trial Site — Boston, Massachusetts, United States
- Clinical Trial Site — Springfield, Massachusetts, United States
- Clinical Trial Site — Detroit, Michigan, United States
- Clinical Trial Site — Jackson, Mississippi, United States
- Clinical Trial Site — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.